nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—SLC6A3—nerve—acquired immunodeficiency syndrome	0.0157	0.125	CbGeAlD
Lisdexamfetamine—SLC18A2—blood plasma—acquired immunodeficiency syndrome	0.0157	0.125	CbGeAlD
Lisdexamfetamine—Amphetamine—CARTPT—acquired immunodeficiency syndrome	0.0129	0.523	CrCbGaD
Lisdexamfetamine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.0126	0.101	CbGeAlD
Lisdexamfetamine—L-Phenylalanine—TAT—acquired immunodeficiency syndrome	0.0118	0.478	CrCbGaD
Lisdexamfetamine—SLC18A2—digestive system—acquired immunodeficiency syndrome	0.00603	0.048	CbGeAlD
Lisdexamfetamine—SLC18A2—blood—acquired immunodeficiency syndrome	0.00574	0.0457	CbGeAlD
Lisdexamfetamine—SLC18A2—vagina—acquired immunodeficiency syndrome	0.00532	0.0424	CbGeAlD
Lisdexamfetamine—SLC18A2—lung—acquired immunodeficiency syndrome	0.00503	0.0401	CbGeAlD
Lisdexamfetamine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.00471	0.0375	CbGeAlD
Lisdexamfetamine—SLC18A2—nervous system—acquired immunodeficiency syndrome	0.00466	0.0371	CbGeAlD
Lisdexamfetamine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.00453	0.0361	CbGeAlD
Lisdexamfetamine—SLC18A2—central nervous system—acquired immunodeficiency syndrome	0.00449	0.0357	CbGeAlD
Lisdexamfetamine—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.00418	0.0333	CbGeAlD
Lisdexamfetamine—SLC6A3—lung—acquired immunodeficiency syndrome	0.00381	0.0303	CbGeAlD
Lisdexamfetamine—ADRA1B—brain—acquired immunodeficiency syndrome	0.0036	0.0286	CbGeAlD
Lisdexamfetamine—SLC18A2—brain—acquired immunodeficiency syndrome	0.00356	0.0284	CbGeAlD
Lisdexamfetamine—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.00353	0.0281	CbGeAlD
Lisdexamfetamine—SLC18A2—lymph node—acquired immunodeficiency syndrome	0.00344	0.0274	CbGeAlD
Lisdexamfetamine—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.00339	0.027	CbGeAlD
Lisdexamfetamine—SLC6A2—lung—acquired immunodeficiency syndrome	0.00307	0.0244	CbGeAlD
Lisdexamfetamine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.00284	0.0226	CbGeAlD
Lisdexamfetamine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.00274	0.0218	CbGeAlD
Lisdexamfetamine—SLC6A3—brain—acquired immunodeficiency syndrome	0.00269	0.0214	CbGeAlD
Lisdexamfetamine—SLC6A2—brain—acquired immunodeficiency syndrome	0.00217	0.0173	CbGeAlD
Lisdexamfetamine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.0021	0.0167	CbGeAlD
Lisdexamfetamine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00145	0.00171	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00145	0.0017	CcSEcCtD
Lisdexamfetamine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00144	0.0017	CcSEcCtD
Lisdexamfetamine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.00144	0.00169	CcSEcCtD
Lisdexamfetamine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00144	0.00169	CcSEcCtD
Lisdexamfetamine—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.00143	0.00169	CcSEcCtD
Lisdexamfetamine—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.00142	0.00168	CcSEcCtD
Lisdexamfetamine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00142	0.00168	CcSEcCtD
Lisdexamfetamine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00142	0.00168	CcSEcCtD
Lisdexamfetamine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00142	0.00167	CcSEcCtD
Lisdexamfetamine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00142	0.00167	CcSEcCtD
Lisdexamfetamine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00142	0.00167	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00142	0.00167	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00142	0.00167	CcSEcCtD
Lisdexamfetamine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00142	0.00167	CcSEcCtD
Lisdexamfetamine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00141	0.00166	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00141	0.00166	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00141	0.00166	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00141	0.00166	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00141	0.00166	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00141	0.00166	CcSEcCtD
Lisdexamfetamine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00141	0.00165	CcSEcCtD
Lisdexamfetamine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.0014	0.00165	CcSEcCtD
Lisdexamfetamine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.0014	0.00165	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.0014	0.00164	CcSEcCtD
Lisdexamfetamine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00139	0.00164	CcSEcCtD
Lisdexamfetamine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00139	0.00164	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00139	0.00164	CcSEcCtD
Lisdexamfetamine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.00139	0.00163	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00139	0.00163	CcSEcCtD
Lisdexamfetamine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00138	0.00163	CcSEcCtD
Lisdexamfetamine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00138	0.00163	CcSEcCtD
Lisdexamfetamine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.00138	0.00162	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00137	0.00161	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00136	0.00161	CcSEcCtD
Lisdexamfetamine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00136	0.0016	CcSEcCtD
Lisdexamfetamine—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00136	0.0016	CcSEcCtD
Lisdexamfetamine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00136	0.0016	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00135	0.00159	CcSEcCtD
Lisdexamfetamine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00134	0.00158	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00134	0.00158	CcSEcCtD
Lisdexamfetamine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00134	0.00158	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00134	0.00158	CcSEcCtD
Lisdexamfetamine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.00133	0.00157	CcSEcCtD
Lisdexamfetamine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00133	0.00157	CcSEcCtD
Lisdexamfetamine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00133	0.00157	CcSEcCtD
Lisdexamfetamine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00133	0.00156	CcSEcCtD
Lisdexamfetamine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00133	0.00156	CcSEcCtD
Lisdexamfetamine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00133	0.00156	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00132	0.00155	CcSEcCtD
Lisdexamfetamine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00132	0.00155	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00132	0.00155	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00132	0.00155	CcSEcCtD
Lisdexamfetamine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00131	0.00154	CcSEcCtD
Lisdexamfetamine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.00131	0.00154	CcSEcCtD
Lisdexamfetamine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00131	0.00154	CcSEcCtD
Lisdexamfetamine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00131	0.00154	CcSEcCtD
Lisdexamfetamine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.0013	0.00153	CcSEcCtD
Lisdexamfetamine—Rash—Didanosine—acquired immunodeficiency syndrome	0.0013	0.00153	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.0013	0.00153	CcSEcCtD
Lisdexamfetamine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.0013	0.00153	CcSEcCtD
Lisdexamfetamine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00129	0.00152	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00129	0.00152	CcSEcCtD
Lisdexamfetamine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00129	0.00151	CcSEcCtD
Lisdexamfetamine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00128	0.00151	CcSEcCtD
Lisdexamfetamine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00128	0.00151	CcSEcCtD
Lisdexamfetamine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00128	0.00151	CcSEcCtD
Lisdexamfetamine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00128	0.0015	CcSEcCtD
Lisdexamfetamine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00127	0.0015	CcSEcCtD
Lisdexamfetamine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00127	0.0015	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00127	0.0015	CcSEcCtD
Lisdexamfetamine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00127	0.00149	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00127	0.00149	CcSEcCtD
Lisdexamfetamine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00126	0.00149	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00126	0.00149	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00126	0.00148	CcSEcCtD
Lisdexamfetamine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00126	0.00148	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00125	0.00147	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00125	0.00147	CcSEcCtD
Lisdexamfetamine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00125	0.00147	CcSEcCtD
Lisdexamfetamine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00125	0.00147	CcSEcCtD
Lisdexamfetamine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00124	0.00146	CcSEcCtD
Lisdexamfetamine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00124	0.00145	CcSEcCtD
Lisdexamfetamine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00123	0.00145	CcSEcCtD
Lisdexamfetamine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00123	0.00145	CcSEcCtD
Lisdexamfetamine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00123	0.00145	CcSEcCtD
Lisdexamfetamine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00123	0.00145	CcSEcCtD
Lisdexamfetamine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00123	0.00145	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00123	0.00145	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00123	0.00144	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00122	0.00144	CcSEcCtD
Lisdexamfetamine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00122	0.00144	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00122	0.00143	CcSEcCtD
Lisdexamfetamine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00121	0.00143	CcSEcCtD
Lisdexamfetamine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00142	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.0012	0.00142	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.0012	0.00142	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.0012	0.00141	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00119	0.0014	CcSEcCtD
Lisdexamfetamine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.0014	CcSEcCtD
Lisdexamfetamine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00119	0.0014	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00118	0.00139	CcSEcCtD
Lisdexamfetamine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00118	0.00139	CcSEcCtD
Lisdexamfetamine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00118	0.00139	CcSEcCtD
Lisdexamfetamine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00118	0.00139	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00118	0.00139	CcSEcCtD
Lisdexamfetamine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00118	0.00139	CcSEcCtD
Lisdexamfetamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00118	0.00139	CcSEcCtD
Lisdexamfetamine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00118	0.00139	CcSEcCtD
Lisdexamfetamine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00117	0.00138	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00117	0.00137	CcSEcCtD
Lisdexamfetamine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00117	0.00137	CcSEcCtD
Lisdexamfetamine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00117	0.00137	CcSEcCtD
Lisdexamfetamine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00117	0.00137	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00116	0.00137	CcSEcCtD
Lisdexamfetamine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00116	0.00137	CcSEcCtD
Lisdexamfetamine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00116	0.00137	CcSEcCtD
Lisdexamfetamine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00116	0.00137	CcSEcCtD
Lisdexamfetamine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00136	CcSEcCtD
Lisdexamfetamine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00115	0.00136	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00115	0.00135	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00135	CcSEcCtD
Lisdexamfetamine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00115	0.00135	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00114	0.00134	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00114	0.00134	CcSEcCtD
Lisdexamfetamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00114	0.00134	CcSEcCtD
Lisdexamfetamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00114	0.00134	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00114	0.00134	CcSEcCtD
Lisdexamfetamine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00113	0.00133	CcSEcCtD
Lisdexamfetamine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00113	0.00133	CcSEcCtD
Lisdexamfetamine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00113	0.00133	CcSEcCtD
Lisdexamfetamine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00113	0.00133	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00113	0.00133	CcSEcCtD
Lisdexamfetamine—Rash—Stavudine—acquired immunodeficiency syndrome	0.00113	0.00133	CcSEcCtD
Lisdexamfetamine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00113	0.00133	CcSEcCtD
Lisdexamfetamine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00113	0.00133	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00112	0.00132	CcSEcCtD
Lisdexamfetamine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00112	0.00132	CcSEcCtD
Lisdexamfetamine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00112	0.00132	CcSEcCtD
Lisdexamfetamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00112	0.00132	CcSEcCtD
Lisdexamfetamine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00112	0.00131	CcSEcCtD
Lisdexamfetamine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00111	0.00131	CcSEcCtD
Lisdexamfetamine—Rash—Abacavir—acquired immunodeficiency syndrome	0.00111	0.00131	CcSEcCtD
Lisdexamfetamine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00111	0.00131	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00111	0.00131	CcSEcCtD
Lisdexamfetamine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00111	0.0013	CcSEcCtD
Lisdexamfetamine—Headache—Abacavir—acquired immunodeficiency syndrome	0.0011	0.0013	CcSEcCtD
Lisdexamfetamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.0011	0.00129	CcSEcCtD
Lisdexamfetamine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00129	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00109	0.00128	CcSEcCtD
Lisdexamfetamine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00108	0.00128	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00108	0.00127	CcSEcCtD
Lisdexamfetamine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00108	0.00127	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00108	0.00127	CcSEcCtD
Lisdexamfetamine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.00126	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00107	0.00126	CcSEcCtD
Lisdexamfetamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00107	0.00125	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00106	0.00125	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00125	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00106	0.00125	CcSEcCtD
Lisdexamfetamine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00106	0.00125	CcSEcCtD
Lisdexamfetamine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.00106	0.00124	CcSEcCtD
Lisdexamfetamine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00124	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00105	0.00124	CcSEcCtD
Lisdexamfetamine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00105	0.00123	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00123	CcSEcCtD
Lisdexamfetamine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00123	CcSEcCtD
Lisdexamfetamine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00104	0.00122	CcSEcCtD
Lisdexamfetamine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00104	0.00122	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00104	0.00122	CcSEcCtD
Lisdexamfetamine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00122	CcSEcCtD
Lisdexamfetamine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.00122	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00103	0.00122	CcSEcCtD
Lisdexamfetamine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00103	0.00121	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.0012	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00101	0.00119	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00101	0.00118	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.001	0.00118	CcSEcCtD
Lisdexamfetamine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.001	0.00118	CcSEcCtD
Lisdexamfetamine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.001	0.00118	CcSEcCtD
Lisdexamfetamine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000994	0.00117	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000989	0.00116	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000989	0.00116	CcSEcCtD
Lisdexamfetamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000988	0.00116	CcSEcCtD
Lisdexamfetamine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000986	0.00116	CcSEcCtD
Lisdexamfetamine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00098	0.00115	CcSEcCtD
Lisdexamfetamine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00098	0.00115	CcSEcCtD
Lisdexamfetamine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000979	0.00115	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000976	0.00115	CcSEcCtD
Lisdexamfetamine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000973	0.00115	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000964	0.00113	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000962	0.00113	CcSEcCtD
Lisdexamfetamine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00096	0.00113	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000958	0.00113	CcSEcCtD
Lisdexamfetamine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000956	0.00113	CcSEcCtD
Lisdexamfetamine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000956	0.00112	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000955	0.00112	CcSEcCtD
Lisdexamfetamine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000949	0.00112	CcSEcCtD
Lisdexamfetamine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000937	0.0011	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000934	0.0011	CcSEcCtD
Lisdexamfetamine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000924	0.00109	CcSEcCtD
Lisdexamfetamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000923	0.00109	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000919	0.00108	CcSEcCtD
Lisdexamfetamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000919	0.00108	CcSEcCtD
Lisdexamfetamine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000911	0.00107	CcSEcCtD
Lisdexamfetamine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00091	0.00107	CcSEcCtD
Lisdexamfetamine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000905	0.00107	CcSEcCtD
Lisdexamfetamine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000903	0.00106	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000894	0.00105	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00089	0.00105	CcSEcCtD
Lisdexamfetamine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000881	0.00104	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000877	0.00103	CcSEcCtD
Lisdexamfetamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000868	0.00102	CcSEcCtD
Lisdexamfetamine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000867	0.00102	CcSEcCtD
Lisdexamfetamine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000864	0.00102	CcSEcCtD
Lisdexamfetamine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000861	0.00101	CcSEcCtD
Lisdexamfetamine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00086	0.00101	CcSEcCtD
Lisdexamfetamine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000858	0.00101	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000857	0.00101	CcSEcCtD
Lisdexamfetamine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000855	0.00101	CcSEcCtD
Lisdexamfetamine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000834	0.000982	CcSEcCtD
Lisdexamfetamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000831	0.000977	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000827	0.000973	CcSEcCtD
Lisdexamfetamine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000824	0.000969	CcSEcCtD
Lisdexamfetamine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000823	0.000968	CcSEcCtD
Lisdexamfetamine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000818	0.000963	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000817	0.000962	CcSEcCtD
Lisdexamfetamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000811	0.000954	CcSEcCtD
Lisdexamfetamine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000799	0.00094	CcSEcCtD
Lisdexamfetamine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000796	0.000937	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000796	0.000936	CcSEcCtD
Lisdexamfetamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000776	0.000913	CcSEcCtD
Lisdexamfetamine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000769	0.000905	CcSEcCtD
Lisdexamfetamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000768	0.000904	CcSEcCtD
Lisdexamfetamine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000762	0.000896	CcSEcCtD
Lisdexamfetamine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000761	0.000896	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000759	0.000893	CcSEcCtD
Lisdexamfetamine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000757	0.000891	CcSEcCtD
Lisdexamfetamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000739	0.00087	CcSEcCtD
Lisdexamfetamine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000733	0.000863	CcSEcCtD
Lisdexamfetamine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000733	0.000863	CcSEcCtD
Lisdexamfetamine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000732	0.000862	CcSEcCtD
Lisdexamfetamine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000728	0.000857	CcSEcCtD
Lisdexamfetamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000718	0.000844	CcSEcCtD
Lisdexamfetamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000705	0.00083	CcSEcCtD
Lisdexamfetamine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000699	0.000823	CcSEcCtD
Lisdexamfetamine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000699	0.000822	CcSEcCtD
Lisdexamfetamine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000695	0.000818	CcSEcCtD
Lisdexamfetamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000691	0.000813	CcSEcCtD
Lisdexamfetamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000659	0.000775	CcSEcCtD
